Periadventitial dissection of the superior mesenteric artery for locally advanced pancreatic cancer: Surgical planning with the “halo sign” and “string sign”

2020/10/06 by Joseph R. Habib, Benedict Kinny‐Köster, Benedict Kinny-Köster +10 · 66 citations
Medicine · #Cancer #Dissection (medical) #Internal medicine #Medicine #Neuroendocrine Tumor Research Advances #Pancreatic and Hepatic Oncology Research #Pancreatic cancer #Radiology #Renal cell carcinoma treatment #SMA* #Superior mesenteric artery #Surgery

paper · doi:10.1016/j.surg.2020.08.031

published in Surgery 169(5), 1026-1031 (Elsevier BV)

openalex publication_date 2020/10/06 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Citations

• Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
• Cancer statistics, 2019

Cited by

• Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy-Arterial Resection, Arterial Divestment and Total Pancreatectomy. [europepmc]
• Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy. [europepmc]
• Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer. [europepmc]
• Favorable tumor biology in locally advanced pancreatic cancer-beyond CA19-9. [europepmc]
• Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)-basis and current status. [europepmc]
• The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience. [europepmc]
• Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer. [europepmc]
• Added value of 3T MRI and the MRI-halo sign in assessing resectability of locally advanced pancreatic cancer following induction chemotherapy (IMAGE-MRI): prospective pilot study. [europepmc]
• Intraoperative Ultrasound During Surgical Exploration in Patients with Pancreatic Cancer and Vascular Involvement (ULTRAPANC): A Prospective Multicenter Study. [europepmc]
• Assessment of the level III of Inoue by preoperative endoscopic ultrasound and elastography: a novel approach to predict a periarterial divestment technique in borderline resectable (BR) or locally advanced (LA) pancreatic adenocarcinoma-How I do it. [europepmc]
• Anatomical and Biological Considerations to Determine Resectability in Pancreatic Cancer. [europepmc]
• The value of CA19-9 dynamics in decision making for treatment of locally advanced pancreatic cancer. [europepmc]
• Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4): study protocol. [europepmc]
• The Impact of Social Determinants on Pancreatic Cancer Care in the United States. [europepmc]
• Pancreatic Cancer Resectability After Neoadjuvant Treatment: An Imaging Challenge. [europepmc]
• [Advances in Surgical Treatment Following Conversion Therapy for Pancreatic Cancer]. [europepmc]
• Intraoperative Elastography in Pancreatic Cancer-Clinical Applications and Systematic Review of the Literature. [europepmc]
• Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection. [europepmc]
• Pancreatic Cancer Frequently Infiltrates the TRIANGLE Compartment: A Surgical Option to Prevent Local Recurrence. [europepmc]
• The Role of a “Conservative” Resection Strategy After Neoadjuvant Treatment for Borderline/Locally Advanced PDAC with Arterial Involvement: A Single-Centre Retrospective Observational Study [europepmc]